Xellia and Kabi Broaden US Antibiotics Offering

New Offerings Of Vancomycin And Ertapenem

 
• By Aidan Fry
  
Syringes
Xellia and Fresenius Kabi have expanded their injectable antibiotics portfolio in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin